# TP0501 - Pharmaco-Scintigraphic-Study

> **NCT02306772** · PHASE1 · COMPLETED · sponsor: **Tillotts Pharma AG** · enrollment: 18 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** TP05 Coating A
- **DRUG:** TP05 Coating B

## Key facts

- **NCT ID:** NCT02306772
- **Lead sponsor:** Tillotts Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306772, "TP0501 - Pharmaco-Scintigraphic-Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02306772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*